Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells.

Di Stefano C, Grazioli P, Fontanella RA, De Cesaris P, D'Amore A, Regno M, Starace D, Padula F, Fiori ME, Canipari R, Stoppacciaro A, Pesce M, Filippini A, Campese AF, Ziparo E, Riccioli A.

Oncotarget. 2018 Jul 20;9(56):30905-30918. doi: 10.18632/oncotarget.25773. eCollection 2018 Jul 20.

2.

KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.

Cocco E, Leo M, Canzonetta C, Di Vito S, Mai A, Rotili D, Di Napoli A, Vecchione A, De Nunzio C, Filetici P, Stoppacciaro A.

Clin Epigenetics. 2018 Apr 4;10:44. doi: 10.1186/s13148-018-0473-4. eCollection 2018.

3.

Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.

Pirozzi N, Stoppacciaro A, Menè P.

J Nephrol. 2018 Aug;31(4):503-510. doi: 10.1007/s40620-017-0458-y. Epub 2017 Nov 18. Review.

PMID:
29151252
4.

Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia.

De Nunzio C, Giglio S, Stoppacciaro A, Gacci M, Cirombella R, Luciani E, Tubaro A, Vecchione A.

Oncotarget. 2017 Feb 7;8(31):50904-50910. doi: 10.18632/oncotarget.15144. eCollection 2017 Aug 1.

5.

Hyperandrogenism in a postmenopausal woman: a rare case of ectopic adrenal cortical gland.

Guarino A, Di Benedetto L, Giovanale V, Rampioni Vinciguerra GL, Stoppacciaro A, Bellati F, Caserta D.

Gynecol Endocrinol. 2017 Mar;33(3):185-187. doi: 10.1080/09513590.2016.1252326. Epub 2017 Jan 19.

PMID:
28102088
6.

[Kidney disease in Sant' Andrea Hospital: a biopsy based epidemiologic study].

Mei M, Menè P, Stoppacciaro A.

G Ital Nefrol. 2016 Jul-Aug;33(4). pii: gin/33.4.3. Italian.

PMID:
27545628
7.

Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance.

Zizza P, Cingolani C, Artuso S, Salvati E, Rizzo A, D'Angelo C, Porru M, Pagano B, Amato J, Randazzo A, Novellino E, Stoppacciaro A, Gilson E, Stassi G, Leonetti C, Biroccio A.

Nucleic Acids Res. 2016 Feb 29;44(4):1579-90. doi: 10.1093/nar/gkv1122. Epub 2015 Oct 27.

8.

Dropped-head in recessive oculopharyngeal muscular dystrophy.

Garibaldi M, Pennisi EM, Bruttini M, Bizzarri V, Bucci E, Morino S, Talerico C, Stoppacciaro A, Renieri A, Antonini G.

Neuromuscul Disord. 2015 Nov;25(11):869-72. doi: 10.1016/j.nmd.2015.08.011. Epub 2015 Sep 7.

PMID:
26494409
9.

Primary renal osteosarcoma: a very rare tumour with an ominous prognosis.

Virgilio E, Lorenzon L, Stoppacciaro A, Ferri M.

ANZ J Surg. 2017 Dec;87(12):1056-1057. doi: 10.1111/ans.13157. Epub 2015 May 6. No abstract available.

PMID:
25943444
10.

Resolution of septic shock in a patient with myelomeningocele (spina bifida) complicated with deforming Elephantiasis Nostras Verrucosa.

Barberi S, Manzione A, Scrivano J, Maresca B, Moioli A, Salvi PF, Stoppacciaro A, Pucci E, Punzo G, Tammaro A, Gaspari AA, Menè P.

J Eur Acad Dermatol Venereol. 2016 Mar;30(3):547-9. doi: 10.1111/jdv.12945. Epub 2015 Jan 26. No abstract available.

PMID:
25623264
11.

TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo.

Gambara G, Desideri M, Stoppacciaro A, Padula F, De Cesaris P, Starace D, Tubaro A, Del Bufalo D, Filippini A, Ziparo E, Riccioli A.

J Cell Mol Med. 2015 Feb;19(2):327-39. doi: 10.1111/jcmm.12379. Epub 2014 Dec 2.

12.

Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.

Porru M, Zappavigna S, Salzano G, Luce A, Stoppacciaro A, Balestrieri ML, Artuso S, Lusa S, De Rosa G, Leonetti C, Caraglia M.

Oncotarget. 2014 Nov 15;5(21):10446-59.

13.

Manipulation of radiation-induced bystander effect in prostate adenocarcinoma by dose and tumor differentiation grade: in vitro study.

Tubin S, Valeriani M, Salerno G, Bracci S, Stoppacciaro A, Cardelli P, Osti MF, De Sanctis V, Minniti G, Maurizi Enrici R.

Int J Radiat Biol. 2015 Feb;91(2):166-71. doi: 10.3109/09553002.2015.959667. Epub 2015 Jan 29.

PMID:
25174735
14.

Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis.

Salvati E, Zizza P, Rizzo A, Iachettini S, Cingolani C, D'Angelo C, Porru M, Randazzo A, Pagano B, Novellino E, Pisanu ME, Stoppacciaro A, Spinella F, Bagnato A, Gilson E, Leonetti C, Biroccio A.

Nucleic Acids Res. 2014 Mar;42(5):2945-57. doi: 10.1093/nar/gkt1289. Epub 2013 Dec 11. Erratum in: Nucleic Acids Res. 2014 Dec 16;42(22):14083.

15.

A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells.

Garufi A, Trisciuoglio D, Porru M, Leonetti C, Stoppacciaro A, D'Orazi V, Avantaggiati M, Crispini A, Pucci D, D'Orazi G.

J Exp Clin Cancer Res. 2013 Oct 7;32:72. doi: 10.1186/1756-9966-32-72.

16.

Primary adenocarcinoma of the renal pelvis: histologic features of a stepwise process from intestinal hyperplasia to dysplasia in a patient with chronic renal abscess.

Sagnotta A, Dente M, Socciarelli F, Cacchi C, Stoppacciaro A, Balducci G.

Int J Surg Pathol. 2014 Apr;22(2):182-5. doi: 10.1177/1066896913502225. Epub 2013 Sep 4.

PMID:
24008439
17.

TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.

Biroccio A, Cherfils-Vicini J, Augereau A, Pinte S, Bauwens S, Ye J, Simonet T, Horard B, Jamet K, Cervera L, Mendez-Bermudez A, Poncet D, Grataroli R, de Rodenbeeke CT, Salvati E, Rizzo A, Zizza P, Ricoul M, Cognet C, Kuilman T, Duret H, Lépinasse F, Marvel J, Verhoeyen E, Cosset FL, Peeper D, Smyth MJ, Londoño-Vallejo A, Sabatier L, Picco V, Pages G, Scoazec JY, Stoppacciaro A, Leonetti C, Vivier E, Gilson E.

Nat Cell Biol. 2013 Jul;15(7):818-28. doi: 10.1038/ncb2774. Epub 2013 Jun 23.

PMID:
23792691
18.

Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.

Galli R, Paone A, Fabbri M, Zanesi N, Calore F, Cascione L, Acunzo M, Stoppacciaro A, Tubaro A, Lovat F, Gasparini P, Fadda P, Alder H, Volinia S, Filippini A, Ziparo E, Riccioli A, Croce CM.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9812-7. doi: 10.1073/pnas.1304610110. Epub 2013 May 28.

19.

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.

Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC, Pellegrini P, Califano D, Pignata S, Losito S, Canzonieri V, Sorio R, Alder H, Wernicke D, Stoppacciaro A, Baldassarre G, Croce CM.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9845-50. doi: 10.1073/pnas.1305472110. Epub 2013 May 22.

20.

Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.

Scarpino S, Duranti E, Giglio S, Di Napoli A, Galafate D, Del Bufalo D, Desideri M, Socciarelli F, Stoppacciaro A, Ruco L.

Thyroid. 2013 Sep;23(9):1127-37. doi: 10.1089/thy.2011.0421. Epub 2013 Aug 27.

PMID:
23617728
21.

Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid.

Misso G, Porru M, Stoppacciaro A, Castellano M, De Cicco F, Leonetti C, Santini D, Caraglia M.

Cancer Biol Ther. 2012 Dec;13(14):1491-500. doi: 10.4161/cbt.22274. Epub 2012 Sep 18.

22.

NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD.

La Scaleia R, Stoppacciaro A, Oliva S, Morrone S, Di Nardo G, Santoni A, Cucchiara S, Palmieri G.

Inflamm Bowel Dis. 2012 Oct;18(10):1910-22. doi: 10.1002/ibd.22899. Epub 2012 Jan 31.

PMID:
22294522
23.

Peripheral and intestinal CD4+ T cells with a regulatory phenotype in pediatric patients with inflammatory bowel disease.

La Scaleia R, Morrone S, Stoppacciaro A, Scarpino S, Antonelli M, Bianchi E, Di Nardo G, Oliva S, Viola F, Cucchiara S, Santoni A, Palmieri G, Uccini S.

J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):563-72. doi: 10.1097/MPG.0b013e3181e4d323.

PMID:
20890221
24.

Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis.

Menè P, Franeta AJ, Conti G, Stoppacciaro A, Chimenz R, Fede A, Gallizzi R, Fede C.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):91-3.

PMID:
20346246
25.

Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion.

D'Eliseo D, Pisu P, Romano C, Tubaro A, De Nunzio C, Morrone S, Santoni A, Stoppacciaro A, Velotti F.

Int J Cancer. 2010 Sep 1;127(6):1283-94. doi: 10.1002/ijc.25135.

26.

Fhit loss in lung preneoplasia: relation to DNA damage response checkpoint activation.

Cirombella R, Montrone G, Stoppacciaro A, Giglio S, Volinia S, Graziano P, Huebner K, Vecchione A.

Cancer Lett. 2010 May 28;291(2):230-6. doi: 10.1016/j.canlet.2009.10.017. Erratum in: Cancer Lett. 2015 Dec 1;369(1):259.

27.

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.

Ciuffreda L, Del Bufalo D, Desideri M, Di Sanza C, Stoppacciaro A, Ricciardi MR, Chiaretti S, Tavolaro S, Benassi B, Bellacosa A, Foà R, Tafuri A, Cognetti F, Anichini A, Zupi G, Milella M.

Neoplasia. 2009 Aug;11(8):720-31.

28.

Renal limited Wegener's granulomatosis.

Del Porto F, Proietta M, Stoppacciaro A, Trappolini M, Menè P, Aliberti G.

Lupus. 2009 May;18(6):567-9. doi: 10.1177/0961203308098632.

PMID:
19395461
29.

COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.

Scarpino S, Duranti E, Stoppacciaro A, Pilozzi E, Natoli G, Sciacchitano S, Luciani E, Ruco L.

J Pathol. 2009 Aug;218(4):487-94. doi: 10.1002/path.2556.

PMID:
19391129
30.

Focal segmental glomerulosclerosis as a complication of graft-versus-host disease.

Fofi C, Barberi S, Stoppacciaro A, Punzo G, Menè P.

Nat Rev Nephrol. 2009 Apr;5(4):236-40. doi: 10.1038/nrneph.2009.11.

PMID:
19322189
31.

The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy.

De Nunzio C, Trucchi A, Miano R, Stoppacciaro A, Fattahi H, Cicione A, Tubaro A.

J Urol. 2009 Mar;181(3):1069-74; discussion 1074-5. doi: 10.1016/j.juro.2008.10.163. Epub 2009 Jan 16.

PMID:
19150546
32.

Isolation and propagation of glomerular mesangial cells.

Menè P, Stoppacciaro A.

Methods Mol Biol. 2009;466:3-17. doi: 10.1007/978-1-59745-352-3_1.

PMID:
19148614
33.

G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.

Leonetti C, Scarsella M, Riggio G, Rizzo A, Salvati E, D'Incalci M, Staszewsky L, Frapolli R, Stevens MF, Stoppacciaro A, Mottolese M, Antoniani B, Gilson E, Zupi G, Biroccio A.

Clin Cancer Res. 2008 Nov 15;14(22):7284-91. doi: 10.1158/1078-0432.CCR-08-0941.

34.

Fibronectin glomerulopathy: an uncommon cause of nephrotic syndrome in systemic lupus erythematosus.

Stoppacciaro A, Pietrucci A, Fofi C, Raffa S, Torrisi MR, Menè P.

NDT Plus. 2008 Aug;1(4):225-7. doi: 10.1093/ndtplus/sfn037. Epub 2008 Apr 14. No abstract available.

35.

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Carè A.

Cancer Res. 2008 Apr 15;68(8):2745-54. doi: 10.1158/0008-5472.CAN-07-2538.

36.

The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.

Tubaro A, De Nunzio C, Trucchi A, Stoppacciaro A, Miano L.

Urology. 2008 Aug;72(2):340-4. doi: 10.1016/j.urology.2007.11.058. Epub 2008 Mar 12.

PMID:
18336888
37.

Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome.

Uccini S, Perotti D, Colarossi C, Stoppacciaro A, Sardella M, Mannarino O, Collini P, Casieri P, Cozzi D, Amoroso L, Spreafico F, Radice P, Dominici C.

Pediatr Blood Cancer. 2008 Sep;51(3):344-8. doi: 10.1002/pbc.21507.

PMID:
18293378
38.

Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.

Salvati E, Leonetti C, Rizzo A, Scarsella M, Mottolese M, Galati R, Sperduti I, Stevens MF, D'Incalci M, Blasco M, Chiorino G, Bauwens S, Horard B, Gilson E, Stoppacciaro A, Zupi G, Biroccio A.

J Clin Invest. 2007 Nov;117(11):3236-47.

39.

Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.

Luzi G, Diamanti AP, Germano V, Laganà B, Di Rosa R, Salemi S, Stoppacciaro A, D'Amelio R.

Clin Immunol. 2007 Nov;125(2):127-30. Epub 2007 Aug 27.

PMID:
17720626
40.

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.

Tentori L, Lacal PM, Muzi A, Dorio AS, Leonetti C, Scarsella M, Ruffini F, Xu W, Min W, Stoppacciaro A, Colarossi C, Wang ZQ, Zhang J, Graziani G.

Eur J Cancer. 2007 Sep;43(14):2124-33. Epub 2007 Aug 21.

PMID:
17714938
41.

Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.

Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A.

Fertil Steril. 2008 May;89(5 Suppl):1490-6. Epub 2007 Aug 13.

PMID:
17706207
42.

Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas.

Scarpino S, Di Napoli A, Stoppacciaro A, Antonelli M, Pilozzi E, Chiarle R, Palestro G, Marino M, Facciolo F, Rendina EA, Webster KE, Kinkel SA, Scott HS, Ruco L.

Clin Exp Immunol. 2007 Sep;149(3):504-12. Epub 2007 Jun 22.

43.

Collagen loss and impaired wound healing is associated with c-Myb deficiency.

Kopecki Z, Luchetti MM, Adams DH, Strudwick X, Mantamadiotis T, Stoppacciaro A, Gabrielli A, Ramsay RG, Cowin AJ.

J Pathol. 2007 Feb;211(3):351-61.

PMID:
17152050
44.

Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis.

Stoppacciaro A, Ferrarini M, Salmaggi C, Colarossi C, Praderio L, Tresoldi M, Beretta AA, Sabbadini MG.

Arthritis Rheum. 2006 Dec;54(12):4018-22.

45.

Gastric metastasis 14 years after mastectomy for breast lobular carcinoma: case report and literature review.

Aurello P, D'Angelo F, Cosenza G, Petrocca S, Stoppacciaro A, Ramacciato G, Ziparo V.

Am Surg. 2006 May;72(5):456-60. Review.

PMID:
16719204
46.

Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice.

Sangaletti S, Gioiosa L, Guiducci C, Rotta G, Rescigno M, Stoppacciaro A, Chiodoni C, Colombo MP.

J Cell Sci. 2005 Aug 15;118(Pt 16):3685-94. Epub 2005 Jul 26.

47.

UDP-glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry.

Giuliani L, Ciotti M, Stoppacciaro A, Pasquini A, Silvestri I, De Matteis A, Frati L, Aglianò AM.

Oncol Rep. 2005 Feb;13(2):185-91.

PMID:
15643497
48.

Scleroderma fibroblasts constitutively express the long pentraxin PTX3.

Luchetti MM, Sambo P, Majlingová P, Svegliati Baroni S, Peri G, Paroncini P, Introna M, Stoppacciaro A, Mantovani A, Gabrielli A.

Clin Exp Rheumatol. 2004 Jan-Feb;22(3 Suppl 33):S66-72.

PMID:
15344601
49.

In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors.

Leonetti C, Scarsella M, Semple SC, Molinari A, D'Angelo C, Stoppacciaro A, Biroccio A, Zupi G.

Int J Cancer. 2004 Jul 10;110(5):767-74.

50.

Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis.

Melani C, Stoppacciaro A, Foroni C, Felicetti F, Caré A, Colombo MP.

Cancer Immunol Immunother. 2004 Jul;53(7):600-8. Epub 2004 Feb 25.

PMID:
14985859

Supplemental Content

Loading ...
Support Center